RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

Fintel reports that on January 10, 2025, RBC Capital upgraded their outlook for KB Home (NYSE:KBH) from Underperform to ...

Fintel reports that on January 10, 2025, RBC Capital initiated coverage of Amentum Holdings (NYSE:AMTM) with a Sector Perform ...

In the last two years, it’s happened for the fifth time. The S&P 500 was up 26% in 2023 and 25% in 2024, for the best ...

RBC Capital analyst Mike Dahl raised the firm’s price target on Vulcan Materials (VMC) to $269 from $259 and keeps a Sector Perform rating on ...

Blake Gwinn, the head of US Rates Strategy at RBC Capital Markets, joins Yahoo Finance's Morning Brief to explain why the ...

After Intra-Cellular Therapies (ITCI) announced that it has entered into a settlement agreement with Sandoz (SDZNY) resolving patent litigation ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten ...